by Joris Van Arensbergen | Sep 17, 2025 | Blog, FACE technology, News, SURE Technology
Annogen is launcing its proprietary SuRE™ platform, which is used for functional annotation and improvement of promoters and enhancers, for applications in crop engineering. The powerful platform provides a massive-scale “blueprint” of a crop’s...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Annogen is thrilled to announce our participation in the upcoming European Society of Gene and Cell Therapy (ESGCT) conference, taking place from October 7th to 10th in beautiful Seville, Spain! As a leading force in advanced therapy innovation, we are eager to...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Barcelona, The Netherlands – September 10, 2025 Lentitek and Annogen join forces to improve the quality and safety of T-cell therapies. This collaboration, jointly announced at the CGTI Leadership Summit today, aims to improve lentivirus-based CAR-T therapies by...
by Joris Van Arensbergen | Sep 10, 2025 | Blog, News, SURE Technology
Our Chief Strategy Officer Martijn Kelder will be speaking at the Cell and Gene Therapy Innovation Leadership Summit in Barcelona, next Thursday at 15:15. His presentation will reveal Annogen’s latest developments in promoter discovery and characterization, revealing...
by admin | Feb 25, 2025 | Blog, SURE Technology
What makes Annogen’s promoter design stand-out from other providers? A valid question. Let’s put this in historical context. Gene promoter design is nothing new: as early as the 1980’s, researchers began to understand different components within promoters, e.g. TATA...
by admin | Apr 1, 2024 | Blog
With more than 5,000 gene therapies in the clinic today [link], decades of promise finally seem to deliver treatments for dozens of rare diseases. Safety and effectiveness are however still major concerns, with short-lived and off-target expression being the main...
